Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by NP Y5 receptor
申请人:AstraZeneca AB
公开号:US07332492B2
公开(公告)日:2008-02-19
Compounds of formula (I):
wherein:
X is a group of formula (B):
and R1, R2, R4, n, x, y and z are as defined within are described.
Processes for their preparation and their use in the treatment of disorders mediated by the neuropeptide Y5 receptor in a warm-blooded animal, such as a human being, are also described.
式子(I)的化合物:其中,X是式子(B)的基团,而R1、R2、R4、n、x、y和z的定义如上所述。本文还描述了它们的制备过程以及在治疗温血动物(如人类)中由神经肽Y5受体介导的疾病中的应用。